Multi-level Intervention for Childhood Cancer Survivorship Care Adherence
(BRIDGES Trial)
Trial Summary
What is the purpose of this trial?
More than 80% of childhood cancer survivors develop serious or life-threatening late effects after cancer therapy, but \<20% receive recommended survivorship care offered at cancer center survivorship clinics. In a shared care model, the investigators propose to investigate an innovative multi-level intervention consisting of: 1) patient survivorship education via telehealth with the cancer center, 2) ongoing patient-tailored education program within the electronic health record patient portal, 3) a structured interactive phone communication between the cancer center and the primary care clinic, and 4) an in-person visit with the primary care clinic for survivorship care with the goal of achieving high rates of adherence to recommended surveillance for late effects, as well as improving patient and physician knowledge and self-efficacy. If this scalable intervention demonstrates patient completion of recommended care comparable to cancer center survivorship clinics, this innovative study has the enormous potential to deliver recommended care to a larger proportion of childhood cancer survivors and reduce survivorship care disparities, while engaging p to integrate survivorship care as part of overall, lifelong health maintenance.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on education and communication for survivorship care, so it's best to discuss your medications with the trial coordinators.
What data supports the effectiveness of the treatment Multi-level Intervention for Childhood Cancer Survivorship Care Adherence?
Research shows that shared care models, which involve collaboration between different healthcare providers, can be effective in improving follow-up care for cancer survivors. This approach has been shown to maintain continuity of care and improve patient outcomes, suggesting it could be beneficial for childhood cancer survivors as well.12345
Is the Multi-level Intervention for Childhood Cancer Survivorship Care Adherence safe for humans?
The research highlights the importance of long-term follow-up care for childhood cancer survivors due to the risk of late-occurring health problems from previous treatments. While the studies emphasize the need for coordinated care and support, they do not specifically address the safety of the Multi-level Intervention itself.12678
How is the Multi-level Intervention for Childhood Cancer Survivorship Care Adherence treatment different from other treatments?
Research Team
Nina Kadan-Lottick, MD, MSPH
Principal Investigator
Georgetown Lombardi Comprehensive Cancer Center
Eligibility Criteria
This trial is for childhood cancer survivors who are 2-4 years post-treatment, cancer-free with a life expectancy of over 2 years, and have not attended a specialty survivorship clinic. Participants must be English or Spanish speakers (including guardians if under 18) and treated at one of the four specified sites.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention
Participants receive a multi-level intervention including telehealth education, EHR patient portal education, structured phone communication, and in-person PCP clinic visit for survivorship care
Follow-up
Participants are monitored for adherence to guideline-recommended surveillance tests and assessed for knowledge, self-efficacy, and process outcomes
Post-intervention Evaluation
Qualitative interviews with participants and PCPs to gather feedback on the intervention
Treatment Details
Interventions
- Multi-level Intervention of shared model of survivorship care
Find a Clinic Near You
Who Is Running the Clinical Trial?
Georgetown University
Lead Sponsor
University of North Carolina, Chapel Hill
Collaborator
University of Colorado, Denver
Collaborator
Hackensack Meridian Health
Collaborator
NYU Langone Health
Collaborator
Seattle Children's Hospital
Collaborator